Emanuel Kreidl | Senior Expert, Principal Scientist
Novartis

Emanuel Kreidl is a seasoned Senior Expert and Principal Scientist at Novartis, with a strong background in biologics research and development. With over 15 years of experience in the pharmaceutical industry, Emanuel has made significant contributions to the field of biologics, particularly in the areas of drug discovery, protein engineering, and bioprocess optimization.

Throughout his career, Emanuel has demonstrated a passion for innovation and a commitment to advancing the field of biologics. His expertise lies in designing novel biologics, optimizing their production processes, and ensuring their safety and efficacy for patients. Emanuel's work has led to the successful development of several biologic therapies that have made a positive impact on patient outcomes.

At Novartis, Emanuel plays a key role in leading cross-functional teams, driving research projects from conception to commercialization, and collaborating with external partners to advance the company's biologics pipeline. His strong leadership skills, scientific acumen, and strategic vision have been instrumental in shaping Novartis' biologics portfolio and driving its success in the competitive pharmaceutical landscape.

Emanuel is a sought-after speaker and thought leader in the biologics field, regularly sharing his insights and expertise at industry conferences and events. His presentation at the Festival of Biologics Basel 2025 promises to offer valuable perspectives on the latest trends and developments in biologics research and development.

Overall, Emanuel Kreidl is a respected professional with a proven track record of excellence in the biologics industry. His dedication to advancing scientific knowledge, driving innovation, and improving patient outcomes makes him a valuable asset to Novartis and a trusted expert in the field of biologics.